| NCT ID | NCT05925465 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mansoura University |
| Condition | Analgesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2027-12-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-08-01 with a primary completion date of 2027-12-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mandibular fractures are among the most common (60-70%) maxillofacial fractures observed in emergency rooms. In the closed reduction (non-surgical), the bone fragments are realigned manually or by using traction devices. The open reduction surgery of mandibular fractures should first ensure the restoration of the occlusion of the mandible to prevent postoperative malocclusion, followed by stabilization by means of rigid fixations such as plates, screws, and rigid intermaxillary blocks in order to minimise any nonunion, malunion, or delayed union of the fracture segments. These surgical procedures are associated with moderate postoperative pain, being the first 24 hours the most intense pain period. Maxillary and mandibular nerve blocks are performed in patients with refractory trigeminal neuralgia. However, there have been few studies evaluating the analgesic effects of these blocks for maxillofacial surgeries.
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) I/II patients, * within the age group of 21-60 years * both sex * scheduled for elective faciomaxillary surgery Exclusion Criteria: * Pregnant or breast-feeding women * Patients with polytrauma * Patients necessitating postoperative ventilation * Oral or facial infection * Coagulopathy * Drug intake for chronic pain * Known allergy to the study drugs * Psychiatric disorder
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05925465 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05925465 currently recruiting?
Yes, NCT05925465 is actively recruiting participants. Contact the research team at mahazed@yahoo.com for enrollment information.
Where is the NCT05925465 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT05925465 clinical trial?
NCT05925465 is sponsored by Mansoura University. The trial plans to enroll 60 participants.